Targeted therapy
This method is also called monoclonal antibody therapy. This treatment uses the laboratory-produced antibodies to attack the infectious particles in the body. Brentuximab vedotin and Rituximab are two approved monoclonal antibodies used for the treatment of lymphoma cancer.